The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), causes mild to severe infection in humans, and to date, it has claimed more than 4.77 million lives across the world. This virus is ...

A new study shows how the single-molecule organization of receptors in a cellular context determines the function of antibodies, opening up new pathways for the development of cancer immunotherapies.

SARS-CoV-2, the virus that causes COVID-19, has mutated many times into new variants, some that we don't hear about because they haven't changed the course of the pandemic, while others have become ...

A new study points to the need for better antibody validation, and outlines a process that other labs can use to make sure the antibodies they work with function properly. A new study points to the ...

Of the nine treatments and preventives for COVID-19 authorized for emergency use by the Food and Drug Administration, three are drugs made from so-called monoclonal antibodies. Such drugs provide ...

A new multi-pronged antibody design could help immune cells receive stronger activation signals against cancer. Researchers at the University of Southampton have identified a new strategy that could ...

A team led by Peter McPherson, PhD, at the Montreal Neurological Institute and Hospital (The Neuro) published a study (“Implementation of an antibody characterization procedure and application to the ...